Last Price$19.1(7.5%)
Market Cap$14.6B
9.9x
Industry median - 4.9x
5Y Historical average - 6.1x
2.9x
Industry median - 1.2x
5Y Historical average - 1.3x
FCF to Interest
(16.4x)
Industry median - (8.8x)
5Y Historical average - (84.5x)
1.9%
Industry median - 3.5%
5Y Historical average - 66.6%
SMMT Health Rating
SMMT Health rating
6.8
SMMT Health rating performance
SMMT Financial Stability & Strength
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
FCF to Interest
Intangibles as % of Total Assets
Competing with SMMT Financial Health
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Net Debt | Health score | Current ratio | Quick ratio | Net Debt to FCF | FCF to Interest | Intangibles as % of Total Assets | Total Debt to Equity |
$14.6B | ($405.1M) | 6.8 | 10.2x | 9.9x | 2.9x | (16.4x) | 0.0% | 1.9% | |
$402.0B | DKK 76.5B | 5.9 | 0.7x | 0.5x | 1.1x | 15.7x | 19.5% | 71.6% | |
$125.5B | ($4,366.4M) | 5.8 | 2.7x | 2.2x | 5.5x | (25.8x) | 3.7% | 10.7% | |
$74.0B | ($15.9B) | 6.9 | 33.5x | 29.7x | (4.4x) | 105.2x | 3.0% | 5.7% | |
$38.1B | N/A | 5.6 | N/A | N/A | N/A | (103.5x) | N/A | N/A | |
$31.3B | ($1,398.5M) | 6.8 | 2.8x | 2.6x | 32.8x | (0.3x) | 0.0% | 1,931.9% | |
$27.1B | (€16.5B) | 6.2 | 7.3x | 7.1x | (16.7x) | 25.3x | 3.9% | 1.3% | |
$15.2B | ($929.0M) | 5.1 | N/A | N/A | (0.3x) | 12.3x | 0.0% | 0.0% | |
$14.8B | ($2,114.5M) | 5.3 | 2.0x | 1.8x | (9.0x) | 103.1x | 2.1% | 1.3% | |
$14.0B | ($2,967.0M) | 6.9 | 5.2x | 4.8x | (2.7x) | 25.2x | 1.1% | 4.7% | |
$1,846.9M | ($1,600.5M) | 5.1 | 1.9x | 1.6x | 1.6x | (113.8x) | 0.9% | 32.1% |
FAQ
What is the Summit Therapeutics Inc. (SMMT) quick ratio?
The Summit Therapeutics Inc. (SMMT) quick ratio is 9.9x, compared to the industry median of 4.9x and the 5-year historical average of 6.1x.
What is the Summit Therapeutics Inc. (SMMT) net debt to Free Cash Flow (FCF) ratio?
The Summit Therapeutics Inc. (SMMT) net debt to FCF ratio is 2.9x, compared to the industry median of 1.2x and the 5-year historical average of (1.3x).
What is Summit Therapeutics Inc. (SMMT) Free Cash Flow (FCF) to interest ratio?
Summit Therapeutics Inc. (SMMT) FCF to interest ratio is (16.4x), compared to the industry median of (8.8x) and the 5-year historical average of (84.5x).
What is the Summit Therapeutics Inc. (SMMT) total debt to equity ratio?
The Summit Therapeutics Inc. (SMMT) total debt to equity ratio is 1.9%, compared to the industry median of 3.5% and the 5-year historical average of 66.6%.